Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines
Wei Teng, Ting‐Tsung Chang, Hwai‐I Yang, Cheng‐Yuan Peng, Chien‐Wei Su, Tung‐Hung Su, Tsung‐Hui Hu, Ming‐Lung Yu, Hung‐Chih Yang, Jaw‐Ching Wu
Topics & Concepts
MedicineInternal medicineHepatocellular carcinomaCohortAntiviral therapyHepatologyIncidence (geometry)GastroenterologyFramingham Risk ScoreReceiver operating characteristicCumulative incidenceAntiviral treatmentChronic hepatitisImmunologyVirusDiseaseOpticsPhysicsHepatitis B Virus StudiesHepatitis C virus researchHepatocellular Carcinoma Treatment and Prognosis